tirzepatide ketosis (Mounjaro): Type 2 Diabetes Drug Guide Tirzepatide Weight Loss Injections in

Lifestyle education and support help people gain long term maintenance tools

Intervention Each study participant received weekly subcutaneous injections of semaglutide (Ozempic) at 1.0-2.0 mg (starting at 0.25 mg and gradually increasing to the target dose 2.0 mg based on patient tolerance)

This type of GLP-1 agonists provides extended glycemic control and cardiovascular benefits

Vitamin C also promotes adrenal health, cardiovascular health, immune function and its a building block of collagen

The recommended maintenance doses are 5 mg, 10 mg, or 15 mg injected subcutaneously once per week for weight reduction and long-term maintenance

Prioritize a protein source at every meal, even if portions are small